RM
Richard Messmann
Medical Oncology
Credentials: ·
Research
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
New England Journal of Medicine · 2021 · 2,264 citations
Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms
Journal of Clinical Oncology · 2001 · 256 citations
Journal of Clinical Oncology · 2013 · Last of 20 authors · 168 citations
- ES
12 papers
William Figg
7 papers
- AS
6 papers
- GM
3 papers
- MM
3 papers
- NL
3 papers
3 papers
3 papers
